Banner Mobile Banner

Join us at FLORetina!

FLORetina is just around the corner, and we have exciting experiences waiting for you! From live surgeries, product demos to hands-on wet labs featuring our latest innovations, there’s so much to discover.

We can’t wait to see you there and share this journey of innovation and excellence together!

Experience 4 Live Surgeries with our distinguished panel of doctors, featuring Stellaris Elite™ and SeeLuma™

LIVE SURGERIES SCHEDULE

Thursday 4th

Prof Tom Williamson (UK)

3:30 PM

Dr Theodoros Giannopoulos (Greece)

5:00 PM

Dr F. Matontí Marseille (France)

6:00 PM

Dr Thomas Papathomas (Greece)

6:30 PM

Friday 5th

Dr A. La Mantia Rome (Italy)

9:30 AM

Saturday 6th

Dr L. Caretti Rome (Italy)

9:15 AM

Prof M. Mura Rome (Italy)

10:45 AM

*Please select an event and book your spot now.

SeeLuma

Next Generation Vitreoretinal Cataract Platform

Attend this session with Lionel Jouet, Vice President, New Product Strategy & Global Marketing at Bausch+Lomb, where breakthrough technologies and next-generation tools that are redefining procedures and improving patient outcomes will be highlighted.

Lionel Jouet, Vice President, New Product Strategy & Global Marketing.

Session Details

Session:            Surgical Innovations
Date:                 Thursday, December 4, 2025
Time:                 11:00 AM – 11:45 AM CEST

Lunch symposium – beyond redness: a new frontier in the treatment of ocular hyperemia

Date: 6th December. 13:15 – 14:00
Moderators: Stanislao Rizzo and Romina Fasciani

Agenda:

Romina Fasciani Welcome and scientific introduction to the Focus on conjunctival hyperemia as an unmet need

Rita Mencucci Low-dose brimonidine: differences compared to other vasoconstrictor therapies

Maria Dolores Romero Clinical experience from Spain

Luigi Fontana Real-life Italian cases: experience

Massimo De Micheli Real-life Italian cases: experience

Emanuela Aragona Real-life Italian cases: Conjunctival hyperemia in DED

Round table with Q&A from the audience “Discussion on patient selection criteria, treatment duration, safety”